Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium acetate is a chemical compound that functions as an electrolyte replenisher and a systemic alkalinizing agent rather than a biological target. It is commonly utilized in intravenous fluids and total parenteral nutrition to provide sodium and to correct metabolic acidosis. The acetate ion within the compound is metabolically converted into bicarbonate in the body, which helps neutralize excess hydrogen ions (PubChem CID 517045). Because it is a small molecule salt and not a protein-based receptor, enzyme, or transporter, it does not fit the traditional definition of a therapeutic target (DrugBank DB09395). Clinically, it is used to manage conditions like hyponatremia and to buffer acidic states in patients with renal impairment or other metabolic disturbances (StatPearls). Monitoring of serum electrolytes and acid-base balance is essential during administration to prevent adverse effects like hypernatremia or edema.
Sodium acetate provides sodium ions to restore electrolyte balance and acetate ions which are metabolized to bicarbonate, acting as a systemic alkalinizer to increase blood pH (PubChem).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium acetate (NaOAc).